Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,734Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 13Pharmacyclics

02 1Olpha

03 1NanoAlvand

04 1Naprod Life Sciences

05 6Alvogen

06 5Bluepharma

07 2Centocor

08 9Janssen-Cilag

09 12Johnson & Johnson Innovative Medicine

10 1Laboratorio Eczane Pharma

11 2Pluviaendo

12 5Sandoz B2B

13 1Teva Pharmaceutical Industries

14 6Zydus Lifesciences

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date : 2013-11-13

Application Number : 205552

Regulatory Info : RX

Registration Country : USA

Abbvie company banner

02

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

Regulatory Info : Dossier Readiness: Q1 2026

Registration Country : Latvia

Ibrutinib

Brand Name :

Dosage Form : Tablet

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Readiness: Q1 2026

Registration Country : Latvia

Olpha

03

arrow
Medlab Asia & Asia Health
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

Regulatory Info :

Registration Country : Iran

Ibrutinib

Brand Name : Bronib

Dosage Form : Hard Gelatin Capsule

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

NanoAlvand

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNaprod is a top player in Oncology & Anesthesia FDF through excellent innovation, discovery of new processes & high-quality production.

Regulatory Info :

Registration Country : India

Ibrutinib

Brand Name :

Dosage Form : Capsules

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Naprod Life Sciences

05

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 70MG

Packaging :

Approval Date : 2017-12-20

Application Number : 205552

Regulatory Info : RX

Registration Country : USA

Abbvie company banner

06

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : TABLET;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date : 2018-02-16

Application Number : 210563

Regulatory Info : RX

Registration Country : USA

Abbvie company banner

07

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : TABLET;ORAL

Dosage Strength : 280MG

Packaging :

Approval Date : 2018-02-16

Application Number : 210563

Regulatory Info : RX

Registration Country : USA

Abbvie company banner

08

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : TABLET;ORAL

Dosage Strength : 420MG

Packaging :

Approval Date : 2018-02-16

Application Number : 210563

Regulatory Info : RX

Registration Country : USA

Abbvie company banner

09

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : TABLET;ORAL

Dosage Strength : 560MG

Packaging :

Approval Date : 2018-02-16

Application Number : 210563

Regulatory Info : DISCN

Registration Country : USA

Abbvie company banner

10

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : SUSPENSION;ORAL

Dosage Strength : 70MG/ML

Packaging :

Approval Date : 2022-08-24

Application Number : 217003

Regulatory Info : RX

Registration Country : USA

Abbvie company banner

11

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 70MG

Packaging :

Approval Date :

Application Number : 217003

Regulatory Info :

Registration Country : USA

Abbvie company banner

12

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : CAPSULE;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number : 217003

Regulatory Info :

Registration Country : USA

Abbvie company banner

13

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : TABLET;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number : 217003

Regulatory Info :

Registration Country : USA

Abbvie company banner

14

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : TABLET;ORAL

Dosage Strength : 230MG

Packaging :

Approval Date :

Application Number : 217003

Regulatory Info :

Registration Country : USA

Abbvie company banner

15

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : TABLET;ORAL

Dosage Strength : 420MG

Packaging :

Approval Date :

Application Number : 217003

Regulatory Info :

Registration Country : USA

Abbvie company banner

16

arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IMBRUVICA

Dosage Form : TABLET;ORAL

Dosage Strength : 560MG

Packaging :

Approval Date :

Application Number : 217003

Regulatory Info :

Registration Country : USA

Abbvie company banner

17

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number : 212763

Regulatory Info :

Registration Country : USA

blank

18

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 280MG

Packaging :

Approval Date :

Application Number : 212763

Regulatory Info :

Registration Country : USA

blank

19

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 420MG

Packaging :

Approval Date :

Application Number : 212763

Regulatory Info :

Registration Country : USA

blank

20

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 560MG

Packaging :

Approval Date :

Application Number : 212763

Regulatory Info :

Registration Country : USA

blank

21

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 70MG

Packaging :

Approval Date :

Application Number : 214498

Regulatory Info :

Registration Country : USA

blank

22

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number : 214498

Regulatory Info :

Registration Country : USA

blank

23

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number : 211267

Regulatory Info :

Registration Country : USA

blank

24

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number : 211350

Regulatory Info :

Registration Country : USA

blank

25

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 70MG

Packaging :

Approval Date : 2021-03-31

Application Number : 211344

Regulatory Info : DISCN

Registration Country : USA

blank

26

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : CAPSULE;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date : 2021-03-31

Application Number : 211344

Regulatory Info : DISCN

Registration Country : USA

blank

27

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 140MG

Packaging :

Approval Date :

Application Number : 214296

Regulatory Info :

Registration Country : USA

blank

28

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 280MG

Packaging :

Approval Date :

Application Number : 214296

Regulatory Info :

Registration Country : USA

blank

29

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 420MG

Packaging :

Approval Date :

Application Number : 214296

Regulatory Info :

Registration Country : USA

blank

30

Medlab Asia & Asia Health
Not Confirmed
arrow
arrow
Medlab Asia & Asia Health
Not Confirmed

IBRUTINIB

Brand Name : IBRUTINIB

Dosage Form : TABLET;ORAL

Dosage Strength : 560MG

Packaging :

Approval Date :

Application Number : 214296

Regulatory Info :

Registration Country : USA

blank